SEC Form 4 · accession 0001144204-16-083941
MusclePharm Corp · MSLP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ryan Charles Drexler
Officer — Executive Chairman · Director
Period of report
Feb 22, 2016
Accepted (ET)
Feb 23, 2016 · 9:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001415684
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionsF1 | $1.89 | Feb 22, 2016 | A | 137,362 | A | May 22, 2016 | Feb 22, 2026 | Common Stock | 137,362 | 137,362 | D |
Explanation of responses
- F1The options were granted under the issuer's 2015 Equity Incentive Compensation Plan pursuant to the terms of the Reporting Person's employment agreement dated February 11, 2016. The options vest on a quarterly basis in eight equal installments, with the first installment vesting on May 22, 2016.